The prevalence of germ-line TP53 mutations in women diagnosed with breast cancer before age 30

Familial Cancer

Volumn 8, Issue 4, 2009, Pages 563-567

  Ginsburg, Ophira M ^a,b   Akbari, Mohammad R ^b   Aziz, Zeba ^c   Young, Robert ^d   Lynch, Henry ^e   Ghadirian, Parviz ^f   Robidoux, Andre ^f   Londono, Julian ^g   Vasquez, Gonzalo ^g   Gomes, Magda ^h,i   Costa, Mauricio Magalhaes ^h   Dimitrakakis, Constantine ^j   Gutierrez, Gustavo ^k   Pilarski, Robert ^l   Royer, Robert ^b   Narod, Steven A ^b  

^a UNIVERSITY OF TORONTO   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c ALLAMA IQBAL MEDICAL COLLEGE   (Pakistan)

^d UNIVERSITY OF SOUTH CAROLINA SCHOOL OF MEDICINE   (United States)

^e CREIGHTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^f CENTRE HOSPITALIER DE L UNIVERSITÉ DE MONTRÉAL   (Canada)

^g UNIVERSIDAD DE ANTIOQUIA   (Colombia)

^h FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

ⁱ FLUMINENSE FEDERAL UNIVERSITY   (Brazil)

^j ALEXANDRA HOSPITAL   (Greece)

^k UNIVERSIDAD DE COSTA RICA   (Costa Rica)

^l OHIO STATE UNIVERSITY   (United States)

more..

Author keywords

Breast cancer; Li Fraumeni; Li Fraumeni like; P53

Indexed keywords

ADULT; ARTICLE; BRCA2 GENE; BREAST CANCER; FAMILIAL CANCER; FAMILY HISTORY; FEMALE; GENE; GENE MUTATION; GENETIC ANALYSIS; GENETIC PREDISPOSITION; GERM CELL; HUMAN; MAJOR CLINICAL STUDY; MISSENSE MUTATION; NUCLEOTIDE SEQUENCE; ONCOGENE; ONSET AGE; PREVALENCE; PRIORITY JOURNAL; RISK FACTOR; SEQUENCE ANALYSIS; TP53 GENE;

ADULT; AGE OF ONSET; BREAST NEOPLASMS; DNA MUTATIONAL ANALYSIS; FEMALE; GENES, P53; GENETIC PREDISPOSITION TO DISEASE; GERM-LINE MUTATION; HUMANS; LI-FRAUMENI SYNDROME; PEDIGREE; PREVALENCE; YOUNG ADULT;

EID: 70449532098     PISSN: 13899600     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10689-009-9287-z     Document Type: Article

References (31)

1. SA Narod WD Foulkes 2004 BRCA1 and BRCA2; 1994 and beyond Nat Rev Cancer 4 665 676 10.1038/nrc1431 1:CAS:528:DC%2BD2cXntFCmsbk%3D 15343273 (Pubitemid 39215065)
2. FP Li JF Fraumeni Jr 1969 Soft tissue sarcomas, breast cancer, and other neoplasms. A familial syndrome? Ann Intern Med 71 747 752 1:STN:280: DyaE3c%2FmtlymtQ%3D%3D 5360287
3. FP Li JF Fraumeni Jr JJ Mulvihill, et al. 1988 A cancer family syndrome in twenty-four kindreds Cancer Res 48 5358 5362 1:STN:280:DyaL1czhtV2htg%3D%3D 3409256
4. JE Garber AM Goldstein AF Kantor, et al. 1991 Follow up study of twenty-four families with Li-Fraumeni syndrome Cancer Res 51 6069 6097
5. D Malkin FP Li LC Strong, et al. 1990 Germline p53 mutations in a familial syndrome of breast cancer, sarcoma, and other neoplasms Science 250 1233 1238 10.1126/science.1978757 1:CAS:528:DyaK3MXjslSisw%3D%3D 1978757
6. JM Birch AL Hartley KJ Tricker, et al. 1994 Prevalence and diversity of constitutional mutations in the p53 gene among 21 Li-Fraumeni families Cancer Res 54 1298 1304 1:CAS:528:DyaK2cXitFCjsbY%3D 8118819
7. A Salmon D Amikam N Sodha S Davidson L Basel-Vanagaite RA Eeles D Abeliovich T Peretz 2007 Rapid development of post-radiotherapy sarcoma and breast cancer in a patient with a novel germline 'de-novo' TP53 mutation Clin Oncol (R Coll Radiol) 19 7 490 493 1:STN:280:DC%2BD2svls1ymsQ%3D%3D
8. ML De Leon Matsuda A Liede E Kwan CA Mapua EM Cutiongco A Tan A Borg SA Narod 2002 BRCA1 and BRCA2 mutations among breast cancer patients from the Philippines Int J Cancer 98 4 596 603 10.1002/ijc.10194 11920621 (Pubitemid 34208562)
9. A Liede IA Malik Z Aziz L Rios Pd Pde E Kwan SA Narod 2002 Contribution of BRCA1 and BRCA2 mutations to breast and ovarian cancer in Pakistan Am J Hum Genet 71 3 595 606 10.1086/342506 1:CAS:528:DC%2BD38XmvFOhtbo%3D 12181777 (Pubitemid 34970130)
10. MC Gomes MM Costa R Borojevic AN Monteiro R Vieira S Koifman RJ Koifman S Li R Royer S Zhang SA Narod 2007 Prevalence of BRCA1 and BRCA2 mutations in breast cancer patients from Brazil Breast Cancer Res Treat 103 3 349 353 10.1007/s10549-006-9378-6 1:CAS:528:DC%2BD2sXmsVOjurs%3D 17063270 (Pubitemid 46944510)
11. Rozen S, Skaletsky HJ (2000) Primer3 on the WWW for general users and for biologist programmers. In: Krawetz S, Misener S (eds) Bioinformatics methods and protocols: methods in molecular biology. Humana Press, New Jersey, pp 365-386
12. MG Reese FH Eeckman D Kulp D Haussler 1997 Improved splice site detection in Genie J Comput Biol 4 3 311 323 10.1089/cmb.1997.4.311 1:CAS:528: DyaK2sXls1Whtbc%3D 9278062
13. PJ Smith C Zhang J Wang SL Chew MQ Zhang AR Krainer 2006 An increased specificity score matrix for the prediction of SF2/ASF-specific exonic splicing enhancers Hum Mol Genet 15 16 2490 2508 10.1093/hmg/ddl171 1:CAS:528: DC%2BD28XotlaisL4%3D 16825284 (Pubitemid 44288702)
14. S Manoukian B Peissel V Pensotti, et al. 2007 Germline mutations of TP53 and BRCA2 genes in breast cancer/sarcoma families Eur J Cancer 43 3 601 606 10.1016/j.ejca.2006.09.024 1:CAS:528:DC%2BD2sXhsVSjsb0%3D 17224268 (Pubitemid 46177595)
15. ME Krasteva EI Georgieva 2006 Germline p53 single-base changes associated with Balkan endemic nephropathy Biochem Biophys Res Commun 342 2 562 567 10.1016/j.bbrc.2006.02.004 1:CAS:528:DC%2BD28XhvVehs7c%3D 16487937 (Pubitemid 43292339)
16. G Keller H Vogelsang I Becker, et al. 2004 Germline mutations of the E-cadherin (CDH1) and TP53 genes, rather than of RUNX3 and HPP1, contribute to genetic predisposition in German gastric cancer patients J Med Genet 41 6 e89 10.1136/jmg.2003.015594 1:STN:280:DC%2BD2czgvFyisA%3D%3D 15173255
17. LR Dearth H Qian T Wang, et al. 2007 Inactive full-length p53 mutants lacking dominant wild-type p53 inhibition highlight loss of heterozygosity as an important aspect of p53 status in human cancers Carcinogenesis 28 2 289 298 10.1093/carcin/bgl132 1:CAS:528:DC%2BD2sXhs1Sku7s%3D 16861262 (Pubitemid 46321844)
18. K Shiraishi S Kato SY Han, et al. 2004 Isolation of temperature-sensitive p53 mutations from a comprehensive missense mutation library J Biol Chem 279 1 348 355 10.1074/jbc.M310815200 1:CAS:528:DC%2BD3sXhtVSqtrfM 14559903 (Pubitemid 38044833)
19. MA Resnick A Inga 2003 Functional mutants of the sequence-specific transcription factor p53 and implications for master genes of diversity Proc Natl Acad Sci USA 100 17 9934 9939 10.1073/pnas.1633803100 1:CAS:528: DC%2BD3sXmvVeju7w%3D 12909720 (Pubitemid 37087046)
20. P Monti P Campomenosi Y Ciribilli, et al. 2003 Characterization of the p53 mutants ability to inhibit p73 beta transactivation using a yeast-based functional assay Oncogene 22 34 5252 5260 10.1038/sj.onc.1206511 1:CAS:528:DC%2BD3sXmt1emsrk%3D 12917626 (Pubitemid 37056087)
21. D Maurici P Monti P Campomenosi, et al. 2001 Amifostine (WR2721) restores transcriptional activity of specific p53 mutant proteins in a yeast functional assay Oncogene 20 27 3533 3540 10.1038/sj.onc.1204428 1:CAS:528: DC%2BD3MXkvValsL8%3D 11429700 (Pubitemid 32619406)
22. PD Smith S Crossland G Parker, et al. 1999 Novel p53 mutants selected in BRCA-associated tumours which dissociate transformation suppression from other wild-type p53 functions Oncogene 18 15 2451 2459 10.1038/sj.onc.1202565 1:CAS:528:DyaK1MXjtV2murw%3D 10229196 (Pubitemid 29206158)
23. JM Flaman V Robert S Lenglet, et al. 1998 Identification of human p53 mutations with differential effects on the bax and p21 promoters using functional assays in yeast Oncogene 16 10 1369 1372 10.1038/sj.onc.1201889 1:CAS:528:DyaK1cXit1KltLc%3D 9546439
24. Tinat J, Bougeard G, Baert-Desurmont et al (2009) 2009 version of the Chompret criteria for Li-Fraumeni syndrome. J Clin Oncol (Epub August)
25. A-L Borresen TI Andersen J Garber, et al. 1992 Screening for germ line TP53 mutations in breast cancer patients Cancer Res 52 3234 3236 1:STN:280:DyaK383nsVeqsg%3D%3D 1591732
26. RA Eeles 1995 Germline mutations in the TP53 gene Cancer Surv 25 10 24
27. F Laloo J Varley A Moran, et al. 2006 BRCA1, BRCA2 and TP53 mutations in very early-onset breast cancer with associated risks to relatives Eur J Cancer 42 1143 1150 10.1016/j.ejca.2005.11.032
28. KD Gonzalez KA Noltner CH Buzin D Gu CY Wen-Fung Q Nguyen JH Han, et al. 2009 Beyond Li-Fraumeni syndrome, clinical characteristics of families with p53 germline mutations J Clin Oncol 27 1250 1256 10.1200/JCO.2008.16.6959 1:CAS:528:DC%2BD1MXktFKhsLg%3D 19204208
29. G Bougeard R Sesboue S Baert-Desurmont, et al. 2008 Molecular basis of the Li-Fraumeni syndrome: an update from the French LFS families J Med Genet 45 8 535 538 10.1136/jmg.2008.057570 1:STN:280:DC%2BD1cvpt1SlsQ%3D%3D 18511570
30. DG Evans CL Wu JM Birch 2008 BRCA2: a cause of the Li-Fraumeni like syndrome J Med Genet 45 62 63 10.1136/jmg.2007.054494 1:STN:280: DC%2BD1c%2FhtFOjug%3D%3D 18178637 (Pubitemid 351158161)
31. T Walsh S Casadei KH Coats, et al. 2006 Spectrum of mutations in BRCA1, BRCA2, CHEK2 and TP53 in families at high risk of breast cancer JAMA 295 12 1379 1388 10.1001/jama.295.12.1379 1:CAS:528:DC%2BD28Xislehurs%3D 16551709